Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_2
1
17%
Ph phase_3
5
83%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(2)

Detailed Status

Completed4
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 35 (83.3%)

Trials by Status

completed467%
terminated233%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

NCT00487994
completedphase_3

Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

NCT00268697
terminatedphase_3

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

NCT00532558
completedphase_3

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

NCT00143663
terminatedphase_2

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

NCT00865228
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00487994Phase 3

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

Completed
NCT00268697Phase 3

Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

Completed
NCT00532558Phase 3

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Terminated
NCT00143663Phase 3

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

Completed
NCT00865228Phase 2

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Terminated
NCT00868127Phase 3

Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6